Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3139 publications
Blood biomarkers and medication response following group psychotherapy as an add-on treatment in refractory idiopathic myelodysplasia.
Journal: Journal of psychosocial oncology
Published: September 23, 2025
Impact of intravenous iron or exogenous erythropoietin on hemoglobin mass, exercise performance, and acute mountain sickness during altitude acclimatization.
Journal: Journal of applied physiology (Bethesda, Md. : 1985)
Published: September 05, 2025
Hepcidin values can help predict the responsiveness of roxadustat for treating anemia in patients with chronic kidney disease.
Journal: Laboratory medicine
Published: September 01, 2025
Identification of Candidate Blood Biomarkers of Recombinant Human Erythropoietin Administration Using Targeted Polar Metabolomics by HILIC-MS/MS.
Journal: Drug testing and analysis
Published: June 05, 2025
Characterization of the glycosylation profile of erythropoiesis-stimulating agents (ESAs) and impact on potency.
Journal: Journal of pharmaceutical and biomedical analysis
Published: June 02, 2025
Effect of Erythropoiesis-Stimulating Agent Types on Hemoglobin Variability in Hemodialysis Patients.
Effect of Erythropoiesis-Stimulating Agent Types on Hemoglobin Variability in Hemodialysis Patients.
Journal: Journal of clinical medicine
Published: May 18, 2025
Darbepoetin alfa use in trauma and acute care surgery patients who abstain from blood products: A case series and discussion.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: May 02, 2025
Updating the Brazilian clinical practice guidelines for sickle cell disease: Recommendations and development process.
Journal: Hematology, transfusion and cell therapy
Published: April 28, 2025
Transcriptomic Biomarkers in Blood Indicative of the Administration of Recombinant Human Erythropoietin to Thoroughbred Horses.
Journal: Drug testing and analysis
Published: April 03, 2025
Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Lower-Risk Myelodysplastic Syndromes in the COMMANDS Trial.
Journal: Advances in therapy
Published: March 07, 2025
Over eight years of transfusion independence with continuous erythropoietin receptor activator and Roxadustat in transfusion-dependent low-risk myelodysplastic syndrome.
Journal: Oxford medical case reports
Published: February 17, 2025
Vadadustat (Vafseo) for anemia of chronic kidney disease.
Journal: The Medical letter on drugs and therapeutics
Published: February 13, 2025
Last Updated: 10/31/2025